Research and Markets (http://www.researchandmarkets.com/research/4dq2s3/seasonal) has announced the addition of the "Seasonal Influenza-Pipeline Insights" subscription to their offering.

This Seasonal Influenza-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Seasonal Influenza.

This report provides information on therapeutic development based on Seasonal Influenza dealing with all the pipeline drugs, comparative analysis at various stages, covering Filed, Phase III, Phase II, Phase I, IND Filed, Pre-Clinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule-type drug information.

The report also covers the companies' information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

  1. Seasonal Influenza Overview
  2. Seasonal Influenza Pipeline Therapeutics
  3. Seasonal Influenza Therapeutics under Development by Companies
  4. Seasonal Influenza Late Stage Products (Filed and Phase III)
  5. Comparative Analysis
  6. Seasonal Influenza Mid-Clinical Stage Products (Phase II)
  7. Comparative Analysis
  8. Seasonal Influenza Early Clinical Stage Products (Phase I and IND Filed)
  9. Comparative Analysis
  10. Seasonal Influenza Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Seasonal Influenza - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Seasonal Influenza - Discontinued Products
  19. Seasonal Influenza - Dormant Products
  20. Companies Involved in Therapeutics Development for Seasonal Influenza
  21. Appendix

For more information visit http://www.researchandmarkets.com/research/4dq2s3/seasonal.